PharmaTraining Services, London UK
11 & 12 December 2007
DAY 1 Stability testing in context – what we do and why *Preclinical *Clinical trial *Formulation development *Product registration *Post approvalHistory of stability testing *How we got to where we are *Role of ICH *Overview of ICH guidance relevant to stability testing *Stability testing *Impurities *Specification *Detailed review of ICH stability testing documents ICH Q1A Analytical Method Selection and Development LUNCH Defining and setting specifications – ICH Guidance Q6A *Preclinical *Clinical trial *Product registration Analytical Method Validation *Key techniques *Method Selection *Outsourcing of stability testing Question and Answer session DAY 2 Matrixing and bracketing pitfalls and purpose – ICH guidance Q1D Quality systems issues *Safeguarding data quality Shelf lives and expiration dating – interpreting and using data. *Applying ICH Guidance Q1E Out spec and out of trend data. Assessing outliers. LUNCH Photostability testing of new dosage forms ICH Q1B *History, purpose and implementation of guidance Applications/case studies *Case 1 syrup preformulation paper *Case 2 tablet formulation selection *Case 3 Definitive testing *Case 4 Busulfan liquid Group discussion, problem solving and consultancy
|